Data integration Aged Antisynthetase AAV vector Adolescence Prognosis Lysosomal storage diseases Anti-interleukin-6 Adeno-associated vector Acute Kidney Injury/epidemiology/etiology Gene therapy Biopsy Cardio-oncology Inflammation Assisted communication devices Autoimmunity Active Abnormal movement Auto-immunité Immune checkpoint inhibitors Auto-antibodies Anticorps anti-agalsidase DM Inflammatory myopathy COVID-19 Cytokines Anti-drug antibodies IBM Middle Aged Biomarqueurs Female Multidisciplinarity Systems biology Adeno-associated virus Polymyositis IMNM Case reports Arthritis Autoimmune diseases Male Myocarditis B cell homeostasis Auto‐antibodies Deep immune profiling Analyses multidimensionnelles Myopathy Dependovirus/genetics/immunology Myositis and muscle disease Outcome measures Interferon Mass cytometry Anti-IgE IgG Acid-alpha-glucosidase Anti‐mitochondrial antibodies Anti-MDA5 autoantibodies Amyotrophic lateral sclerosis Anti-Mi2 Muscle Adverse drug reactions Antibodies Machine learning AAV Idiopathic inflammatory myopathies Agalsidase Skeletal muscle Adult Bioelectrical impedance analysis Fabry disease Biomarkers Biomarker Antibody responses Inborn errors of metabolism Cancer Myositis Inclusion body myositis Anticorps spécifique des myosites Dermatomyositis Aldosterone Adeno-associated virus vector Humans Anémie hémolytique Interstitial lung disease Amyotrophy Immunotherapy Pharmacology Autoantibodies Antiphospholipid syndrome Anti-synthetase syndrome Anti-agalsidase antibodies AAV humoral immunity Autoantibody AAV antibody Aldostérone Adjudication B-lymphocyte Antisynthétase Sphingosine-1-phosphate Animals Antisynthetase syndrome AAV vectors